000 | 01892cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030906.0 | ||
008 | 131124s2012 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.26.Ph.D.2012.He.A | ||
100 | 0 | _aHebat Allah Salah Ahmad Yousuf | |
245 | 1 | 0 |
_aAssessment of anti-schistosomal activity of mefloquine, in experimental schistosoma mansoni infection / _cHebat Allah Salah Ahmad Yousuf ; Supervised Omaima Mohammed Aboushady , Soheir Sayed Mohammed Mahmoud , Dina Omar Helmy |
246 | 1 | 5 | _aتقييم مدى فاعلية الميفلوكين على العدوى التجريبيه بالبلهارسيا المعويه |
260 |
_aCairo : _bHebat Allah Salah Ahmad Yousuf , _c2012 |
||
300 |
_a160 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Parasitology | ||
520 | _aIt has been recently documented that the antimalarial drug mefloquine (MFQ) had interesting anti-schistosomal properties. This study aimed to assess the effect of single oral dose of mefloquine (400 mg/kg) and single oral dose of mefloquine (200 mg/kg) combined with praziquantel (500 mg/kg) on experimental Schistosoma mansoni infection. Mefloquine significantly reduced the worm burden, tissue egg load, number of liver granulomas and increased the percent of the dead ova within the granulomas | ||
530 | _aIssued also as CD | ||
653 | 4 | _aMefloquine | |
653 | 4 | _aPraziquantel | |
653 | 4 | _aS. mansoni | |
700 | 0 |
_aDina Omar Helmy , _eSupervisor |
|
700 | 0 |
_aOmaima Mohammed Aboushady , _eSupervisor |
|
700 | 0 |
_aSoheir Sayed Mohammed Mahmoud , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSamia _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c44161 _d44161 |